Literature DB >> 24846172

Mechanisms of transcriptional activation of the mouse claudin-5 promoter by estrogen receptor alpha and beta.

Malgorzata Burek1, Katrin Steinberg2, Carola Y Förster3.   

Abstract

Claudin-5 is an integral membrane protein and a critical component of endothelial tight junctions that control paracellular permeability. Claudin-5 is expressed at high levels in the brain vascular endothelium. Estrogens have multiple effects on vascular physiology and function. The biological actions of estrogens are mediated by two different estrogen receptor (ER) subtypes, ER alpha and ER beta. Estrogens have beneficial effects in several vascular disorders. Recently we have cloned and characterized a murine claudin-5 promoter and demonstrated 17beta-estradiol (E2)-mediated regulation of claudin-5 in brain and heart microvascular endothelium on promoter, mRNA and protein level. Sequence analysis revealed a putative estrogen response element (ERE) and a putative Sp1 transcription factor binding site in the claudin-5 promoter. The aim of the present study was to further characterize the estrogen-responsive elements of claudin-5 promoter. First, we introduced point mutations in ERE or Sp1 site in -500/+111 or in Sp1 site of -268/+111 claudin-5 promoter construct, respectively. Basal and E2-mediated transcriptional activation of mutated constructs was abrogated in the luciferase reporter gene assay. Next, we examined whether estrogen receptor subtypes bind to the claudin-5 promoter region. For this purpose we performed chromatin immunoprecipitation assays using anti-estrogen receptor antibodies and cellular lysates of E2-treated endothelial cells followed by quantitative PCR analysis. We show enrichment of claudin-5 promoter fragments containing the ERE- and Sp1-binding site in immunoprecipitates after E2 treatment. Finally, in a gel mobility shift assay, we demonstrated DNA-protein interaction of both ER subtypes at ERE. In summary, this study provides evidence that both a non-consensus ERE and a Sp1 site in the claudin-5 promoter are functional and necessary for the basal and E2-mediated activation of the promoter.
Copyright © 2014 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  17beta-estradiol; Blood–brain barrier; Claudin-5; Estrogen receptor; Promoter; Tight junction

Mesh:

Substances:

Year:  2014        PMID: 24846172     DOI: 10.1016/j.mce.2014.05.003

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  12 in total

1.  Roles of claudin-5 and von Willebrand factor in patients with rheumatoid arthritis.

Authors:  Gönül Gurol; Ihsan Hakkı Ciftci; Halil Harman; Engin Karakece; Ayhan Kamanli; Ibrahim Tekeoglu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 2.  Minireview: Steroid/nuclear receptor-regulated dynamics of occluding and anchoring junctions.

Authors:  Gary L Firestone; Bhumika J Kapadia
Journal:  Mol Endocrinol       Date:  2014-09-09

Review 3.  Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets.

Authors:  Richard F Keep; Anuska V Andjelkovic; Jianming Xiang; Svetlana M Stamatovic; David A Antonetti; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-08       Impact factor: 6.200

4.  BRCA1 represses DNA replication initiation through antagonizing estrogen signaling and maintains genome stability in parallel with WEE1-MCM2 signaling during pregnancy.

Authors:  Xiaoling Xu; Eric Chen; Lihua Mo; Lei Zhang; Fangyuan Shao; Kai Miao; Jianlin Liu; Sek Man Su; Monica Valecha; Un In Chan; Hongping Zheng; Mark Chen; Weiping Chen; Qiang Chen; Haiqing Fu; Mirit I Aladjem; Yanzhen He; Chu-Xia Deng
Journal:  Hum Mol Genet       Date:  2019-03-01       Impact factor: 6.150

5.  Dexamethasone suppresses JMJD3 gene activation via a putative negative glucocorticoid response element and maintains integrity of tight junctions in brain microvascular endothelial cells.

Authors:  Wonho Na; Jee Y Shin; Jee Y Lee; Sangyun Jeong; Won-Sun Kim; Tae Y Yune; Bong-Gun Ju
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-24       Impact factor: 6.200

6.  17β-Estradiol Ameliorates Tight Junction Disruption via Repression of MMP Transcription.

Authors:  Wonho Na; Jee Youn Lee; Won-Sun Kim; Tae Young Yune; Bong-Gun Ju
Journal:  Mol Endocrinol       Date:  2015-07-13

7.  Progesterone and HMOX-1 promote fetal growth by CD8+ T cell modulation.

Authors:  María Emilia Solano; Mirka Katharina Kowal; Greta Eugenia O'Rourke; Andrea Kristina Horst; Kathrin Modest; Torsten Plösch; Roja Barikbin; Chressen Catharina Remus; Robert G Berger; Caitlin Jago; Hoang Ho; Gabriele Sass; Victoria J Parker; John P Lydon; Francesco J DeMayo; Kurt Hecher; Khalil Karimi; Petra Clara Arck
Journal:  J Clin Invest       Date:  2015-03-16       Impact factor: 14.808

Review 8.  Claudin-5: gatekeeper of neurological function.

Authors:  Chris Greene; Nicole Hanley; Matthew Campbell
Journal:  Fluids Barriers CNS       Date:  2019-01-29

Review 9.  The restorative role of annexin A1 at the blood-brain barrier.

Authors:  Simon McArthur; Rodrigo Azevedo Loiola; Elisa Maggioli; Mariella Errede; Daniela Virgintino; Egle Solito
Journal:  Fluids Barriers CNS       Date:  2016-09-21

Review 10.  The Critical Period for Neuroprotection by Estrogen Replacement Therapy and the Potential Underlying Mechanisms.

Authors:  Hang Guo; Min Liu; Lixia Zhang; Long Wang; Wugang Hou; Yaqun Ma; Yulong Ma
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.